Dr. Reddy's Laboratories Limited (RDY) Balance Sheet
RDY balance sheet, FY2026
March 31, 2026 · Indian rupees₹567.88B assets = ₹194.95B liabilities + ₹372.92B equity
Both columns are drawn to the same scale: what RDY owns equals what it owes plus shareholders’ equity. Hover a block for its value.
RDY financial health
Current ratio1.80
Comfortable · current assets cover current liabilities 1.80×
Debt / equity0.21
Low leverage · ₹0.21 of debt for each $1 of equity
Equity / assets65.1%
Equity-funded · of assets funded by shareholders
Cash / debt113.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles20.4%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
RDY balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | ₹219.82BFY2017 | ₹567.88BFY2026 | +11.1%/yr | |
| Total liabilities | ₹95.78BFY2017 | ₹194.95BFY2026 | +8.2%/yr | |
| Shareholders’ equity | ₹124.04BFY2017 | ₹369.60BFY2026 | +12.9%/yr | |
| Cash & short-term investments | ₹18.14BFY2017 | ₹86.08BFY2026 | +18.9%/yr | |
| Total debt | ₹49.19BFY2017 | ₹75.81BFY2026 | +4.9%/yr | |
| Net cash (debt) | −₹31.05BFY2017 | ₹10.27BFY2026 | +₹41.3B | |
| Working capital | ₹15.38BFY2017 | ₹131.75BFY2026 | +₹116.4B | |
| Current ratio | 1.18FY2017 | 1.80FY2026 | +0.62 | |
| Debt / equity | 0.40FY2017 | 0.21FY2026 | −0.19 | |
| Shares outstanding | 835.0MFY2017 | 833.3MFY2026 | −0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
RDY assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
RDY liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
RDY debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
RDY balance sheet in Indian rupees
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | ₹86.08B | ₹57.91B | ₹81.47B | ₹61.80B | ₹44.37B | ₹472.9M | ₹340.2M | ₹24.76B | ₹20.97B | ₹18.14B |
| Cash & equivalents | ₹15.06B | ₹14.65B | ₹7.11B | ₹5.78B | ₹14.85B | ₹202.8M | ₹27.1M | ₹2.23B | ₹2.64B | ₹18.14B |
| Short-term investments | ₹71.01B | ₹43.25B | ₹74.36B | ₹56.02B | ₹29.51B | ₹270.0M | ₹313.1M | ₹22.53B | ₹18.33B | ₹14.27B |
| Receivables | ₹99.22B | ₹109.79B | ₹95.34B | ₹83.20B | ₹80.27B | ₹843.7M | ₹816.3M | ₹46.63B | ₹50.20B | ₹45.74B |
| Inventory | ₹75.02B | ₹71.08B | ₹63.55B | ₹48.67B | ₹50.88B | ₹621.1M | ₹463.5M | ₹33.58B | ₹29.09B | ₹28.53B |
| Other current assets | ₹35.69B | ₹11.33B | ₹7.69B | ₹10.58B | ₹6.34B | ₹90.0M | ₹103.2M | ₹9.54B | ₹9.39B | ₹7.97B |
| Total current assets | ₹296.00B | ₹250.11B | ₹248.05B | ₹204.25B | ₹181.86B | ₹2.03B | ₹1.72B | ₹114.50B | ₹109.64B | ₹100.38B |
| Property, plant & equipment (net) | ₹113.63B | ₹97.76B | ₹76.89B | ₹66.46B | ₹62.17B | ₹781.1M | ₹691.8M | ₹54.09B | ₹57.87B | ₹57.16B |
| Goodwill & intangible assets | ₹115.62B | ₹108.61B | ₹41.20B | ₹35.09B | ₹31.66B | ₹550.0M | ₹418.4M | ₹48.27B | ₹48.61B | ₹48.68B |
| Long-term investments | ₹16.37B | ₹15.20B | ₹5.25B | ₹6.09B | ₹7.99B | ₹8.33B | ₹3.09B | ₹3.34B | ₹4.65B | ₹6.84B |
| Other non-current assets | ₹26.26B | ₹21.30B | ₹16.12B | ₹9.96B | ₹9.15B | ₹0 | ₹0 | ₹5.23B | ₹4.83B | ₹6.77B |
| Total assets | ₹567.88B | ₹492.99B | ₹387.52B | ₹321.85B | ₹292.83B | ₹3.63B | ₹3.07B | ₹225.43B | ₹225.60B | ₹219.82B |
| Liabilities | ||||||||||
| Accounts payable | ₹32.75B | ₹20.05B | ₹21.55B | ₹17.86B | ₹15.97B | ₹173.6M | ₹142.0M | ₹10.30B | ₹9.21B | ₹13.42B |
| Short-term debt | ₹63.85B | ₹38.90B | ₹14.03B | ₹12.19B | ₹28.10B | ₹328.4M | ₹274.9M | ₹16.38B | ₹25.62B | ₹43.74B |
| Deferred revenue | — | ₹1.98B | ₹1.44B | ₹1.98B | ₹2.58B | ₹27.8M | ₹25.2M | ₹1.35B | ₹982.0M | ₹819.0M |
| Total current liabilities | ₹164.25B | ₹130.39B | ₹96.04B | ₹85.84B | ₹94.02B | ₹1.14B | ₹962.5M | ₹59.70B | ₹69.69B | ₹85.00B |
| Long-term debt | ₹12.20B | ₹7.86B | ₹5.99B | ₹1.28B | ₹5.75B | ₹6.30B | ₹1.30B | ₹22.00B | ₹25.09B | ₹5.45B |
| Lease obligations | ₹14.41B | ₹4.92B | ₹3.50B | ₹1.28B | ₹2.96B | ₹3.36B | ₹1.79B | ₹609.0M | ₹630.0M | ₹597.0M |
| Other long-term liabilities | ₹18.50B | ₹17.57B | ₹4.94B | ₹3.74B | ₹2.54B | ₹0 | ₹0 | ₹3.53B | ₹4.36B | ₹5.33B |
| Total liabilities | ₹194.95B | ₹155.82B | ₹106.97B | ₹90.86B | ₹102.30B | ₹1.26B | ₹1.02B | ₹85.23B | ₹99.14B | ₹95.78B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | ₹818.5M | ₹834.0M | ₹834.0M | ₹833.0M | ₹832.0M | ₹11.4M | ₹11.0M | ₹830.0M | ₹830.0M | ₹829.0M |
| Retained earnings (deficit) | ₹345.02B | ₹315.79B | ₹265.26B | ₹215.59B | ₹175.71B | ₹2.13B | ₹1.91B | ₹128.65B | ₹113.86B | ₹108.22B |
| Treasury stock | — | — | — | — | — | −₹1.97B | −₹1.01B | −₹535.0M | ₹0 | ₹0 |
| Accumulated other comprehensive income | ₹10.50B | ₹3.98B | ₹653.0M | ₹886.0M | ₹755.0M | ₹127.0M | ₹32.0M | ₹3.04B | ₹3.98B | ₹7.80B |
| Minority interest | ₹3.39B | ₹3.78B | ₹0 | — | — | — | — | ₹0 | ₹0 | ₹0 |
| Total shareholders' equity | ₹369.60B | ₹333.39B | ₹280.55B | ₹230.99B | ₹190.53B | ₹2.37B | ₹2.05B | ₹140.20B | ₹126.46B | ₹124.04B |
| Key figures | ||||||||||
| Total debt | ₹75.81B | ₹46.77B | ₹20.02B | ₹13.47B | ₹33.84B | ₹414.5M | ₹292.2M | ₹38.38B | ₹50.71B | ₹49.19B |
| Net cash (debt) | ₹10.27B | ₹11.14B | ₹61.45B | ₹48.33B | ₹10.52B | ₹58.3M | ₹48.1M | −₹13.62B | −₹29.75B | −₹31.05B |
| Working capital | ₹131.75B | ₹119.72B | ₹152.01B | ₹118.41B | ₹87.84B | ₹887.1M | ₹760.8M | ₹54.80B | ₹39.95B | ₹15.38B |
| Tangible book value | ₹253.98B | ₹224.78B | ₹239.35B | ₹195.90B | ₹158.86B | ₹1.82B | ₹1.63B | ₹91.93B | ₹77.85B | ₹75.37B |
| Shares outstanding | 833.3M | 834.3M | 833.5M | 831.9M | 831.7M | 831.6M | 830.4M | 831.0M | 830.9M | 835.0M |
| Current ratio | 1.80 | 1.92 | 2.58 | 2.38 | 1.93 | 1.78 | 1.79 | 1.92 | 1.57 | 1.18 |
| Quick ratio | 1.13 | 1.29 | 1.84 | 1.69 | 1.33 | 1.15 | 1.20 | 1.20 | 1.02 | 0.75 |
| Debt / equity | 0.21 | 0.14 | 0.07 | 0.06 | 0.18 | 0.18 | 0.14 | 0.27 | 0.40 | 0.40 |
| Equity / assets | 65.1% | 67.6% | 72.4% | 71.8% | 65.1% | 65.2% | 66.7% | 62.2% | 56.1% | 56.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | ₹81.43B | ₹86.08B | ₹82.59B | ₹69.81B | ₹66.69B | ₹57.91B | ₹59.18B | ₹63.07B | ₹94.63B | ₹81.47B | ₹72.36B | ₹67.78B |
| Cash & equivalents | ₹11.20B | ₹15.06B | ₹18.66B | ₹9.91B | ₹9.00B | ₹14.65B | ₹12.29B | ₹11.33B | ₹4.91B | ₹7.11B | ₹7.34B | ₹13.39B |
| Short-term investments | ₹70.22B | ₹71.01B | ₹63.93B | ₹59.91B | ₹57.68B | ₹43.25B | ₹46.89B | ₹51.74B | ₹89.71B | ₹74.36B | ₹65.02B | ₹54.39B |
| Receivables | ₹124.42B | ₹99.22B | ₹124.27B | ₹120.84B | ₹115.44B | ₹109.79B | ₹111.49B | ₹102.84B | ₹81.09B | ₹95.34B | ₹96.08B | ₹89.69B |
| Inventory | ₹80.47B | ₹75.02B | ₹79.01B | ₹75.82B | ₹75.60B | ₹71.08B | ₹71.63B | ₹72.04B | ₹68.57B | ₹63.55B | ₹60.80B | ₹56.59B |
| Other current assets | ₹13.01B | ₹35.69B | ₹11.68B | ₹13.04B | ₹12.17B | ₹11.33B | ₹10.71B | ₹10.18B | ₹24.91B | ₹7.69B | ₹9.25B | ₹3.63B |
| Total current assets | ₹299.33B | ₹296.00B | ₹297.55B | ₹279.52B | ₹269.90B | ₹250.11B | ₹253.02B | ₹248.13B | ₹269.19B | ₹248.05B | ₹238.48B | ₹217.69B |
| Property, plant & equipment (net) | ₹115.55B | ₹113.63B | ₹115.54B | ₹111.98B | ₹102.78B | ₹97.76B | ₹93.05B | ₹86.69B | ₹80.34B | ₹76.89B | ₹72.80B | ₹70.48B |
| Goodwill & intangible assets | ₹116.46B | ₹115.62B | ₹114.73B | ₹113.24B | ₹107.57B | ₹108.61B | ₹104.78B | ₹103.89B | ₹41.37B | ₹41.20B | ₹41.19B | ₹41.28B |
| Long-term investments | ₹15.88B | ₹16.37B | ₹9.95B | ₹9.77B | ₹11.42B | ₹15.20B | ₹9.02B | ₹5.98B | ₹5.21B | ₹5.25B | ₹8.33B | ₹5.92B |
| Other non-current assets | ₹28.08B | ₹26.26B | ₹25.13B | ₹27.50B | ₹27.86B | ₹21.30B | ₹21.19B | ₹21.26B | ₹19.18B | ₹16.12B | ₹12.04B | ₹11.65B |
| Total assets | ₹575.30B | ₹567.88B | ₹562.90B | ₹542.00B | ₹519.54B | ₹492.99B | ₹481.06B | ₹465.95B | ₹415.30B | ₹387.52B | ₹372.84B | ₹347.02B |
| Liabilities | ||||||||||||
| Accounts payable | ₹37.50B | ₹32.75B | ₹40.80B | ₹40.25B | ₹37.46B | ₹20.05B | ₹36.02B | ₹35.78B | ₹34.11B | ₹21.55B | ₹31.11B | ₹30.48B |
| Short-term debt | ₹60.07B | ₹63.85B | ₹56.12B | ₹46.90B | ₹43.55B | ₹38.90B | ₹43.51B | ₹41.18B | ₹24.45B | ₹14.03B | ₹13.70B | ₹7.19B |
| Deferred revenue | ₹1.74B | — | ₹1.78B | ₹2.06B | ₹1.83B | ₹1.98B | ₹2.00B | ₹1.53B | ₹10.33B | ₹1.44B | ₹2.27B | ₹3.00B |
| Total current liabilities | ₹157.34B | ₹164.25B | ₹158.31B | ₹150.93B | ₹142.59B | ₹130.39B | ₹131.95B | ₹129.30B | ₹105.67B | ₹96.04B | ₹93.60B | ₹84.18B |
| Long-term debt | ₹0 | ₹12.20B | ₹0 | ₹11.64B | ₹0 | ₹7.86B | ₹3.80B | ₹7.36B | ₹3.80B | ₹5.99B | ₹3.80B | ₹6.04B |
| Lease obligations | ₹14.26B | ₹14.41B | ₹13.65B | ₹13.58B | ₹6.46B | ₹4.92B | ₹4.88B | ₹4.72B | ₹3.71B | ₹3.50B | ₹3.71B | ₹3.58B |
| Other long-term liabilities | ₹31.23B | ₹18.50B | ₹28.83B | ₹17.36B | ₹23.19B | ₹17.57B | ₹23.74B | ₹20.01B | ₹11.20B | ₹4.94B | ₹7.59B | ₹3.71B |
| Total liabilities | ₹188.57B | ₹194.95B | ₹187.14B | ₹179.92B | ₹165.78B | ₹155.82B | ₹159.49B | ₹156.67B | ₹120.67B | ₹106.97B | ₹104.99B | ₹93.94B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | ₹835.0M | ₹818.5M | ₹835.0M | ₹835.0M | ₹835.0M | ₹834.0M | ₹834.0M | ₹834.0M | ₹834.0M | ₹834.0M | ₹834.0M | ₹834.0M |
| Retained earnings (deficit) | ₹356.42B | ₹345.02B | ₹349.78B | ₹337.68B | ₹329.97B | ₹315.79B | ₹299.35B | ₹285.18B | ₹279.26B | ₹265.26B | ₹252.08B | ₹238.23B |
| Accumulated other comprehensive income | ₹3.98B | ₹10.50B | ₹3.98B | ₹3.98B | ₹3.98B | ₹3.98B | ₹4.48B | ₹4.52B | ₹566.0M | ₹653.0M | ₹762.0M | ₹810.0M |
| Minority interest | ₹3.31B | ₹3.39B | ₹3.39B | ₹3.59B | ₹3.70B | — | — | — | — | — | — | — |
| Total shareholders' equity | ₹383.43B | ₹369.60B | ₹372.37B | ₹358.49B | ₹350.06B | ₹333.39B | ₹317.72B | ₹305.34B | ₹294.63B | ₹280.55B | ₹267.85B | ₹253.09B |
| Key figures | ||||||||||||
| Total debt | ₹71.95B | ₹75.81B | ₹67.73B | ₹58.54B | ₹48.64B | ₹46.77B | ₹51.09B | ₹48.54B | ₹30.68B | ₹20.02B | ₹19.85B | ₹13.23B |
| Net cash (debt) | ₹9.47B | ₹10.27B | ₹14.86B | ₹11.27B | ₹18.04B | ₹11.14B | ₹8.09B | ₹14.53B | ₹63.95B | ₹61.45B | ₹52.51B | ₹54.55B |
| Working capital | ₹141.99B | ₹131.75B | ₹139.24B | ₹128.59B | ₹127.31B | ₹119.72B | ₹121.07B | ₹118.83B | ₹163.51B | ₹152.01B | ₹144.88B | ₹133.51B |
| Tangible book value | ₹266.96B | ₹253.98B | ₹257.64B | ₹245.25B | ₹242.49B | ₹224.78B | ₹212.94B | ₹201.45B | ₹253.25B | ₹239.35B | ₹226.66B | ₹211.81B |
| Shares outstanding | 832.7M | 834.8M | 833.2M | 833.0M | 833.0M | 834.3M | 834.3M | 834.1M | 833.9M | 833.9M | 166.8M | 833.5M |
| Current ratio | 1.90 | 1.80 | 1.88 | 1.85 | 1.89 | 1.92 | 1.92 | 1.92 | 2.55 | 2.58 | 2.55 | 2.59 |
| Quick ratio | 1.31 | 1.13 | 1.31 | 1.26 | 1.28 | 1.29 | 1.29 | 1.28 | 1.66 | 1.84 | 1.80 | 1.87 |
| Debt / equity | 0.19 | 0.21 | 0.18 | 0.16 | 0.14 | 0.14 | 0.16 | 0.16 | 0.10 | 0.07 | 0.07 | 0.05 |
| Equity / assets | 66.6% | 65.1% | 66.2% | 66.1% | 67.4% | 67.6% | 66.0% | 65.5% | 70.9% | 72.4% | 71.8% | 72.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in Indian rupees as reported (latest annual report filed May 29, 2026); data from EODHD.
RDY financial position
At the end of fiscal 2026 (March 31, 2026), Dr. Reddy's Laboratories had total assets of ₹567.9 billion (up 15.2% from a year earlier), total liabilities of ₹195.0 billion and shareholders' equity of ₹369.6 billion. It held ₹86.1 billion in cash and short-term investments against ₹75.8 billion of debt, a net cash position of ₹10.3 billion. Its current ratio was 1.80. In the latest quarter (ended June 30, 2026) total assets were ₹575.3 billion and equity ₹383.4 billion.
Related: RDY income statement, RDY cash flow statement, RDY key metrics. See the RDY stock overview for the latest quote and news.
RDY balance sheet FAQ
What are Dr. Reddy's Laboratories's total assets?
Dr. Reddy's Laboratories reported total assets of ₹567.9 billion at the end of fiscal 2026 (March 31, 2026), compared with ₹493.0 billion a year earlier.
How much debt does Dr. Reddy's Laboratories have?
Dr. Reddy's Laboratories had ₹75.8 billion of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.21.
How much cash does Dr. Reddy's Laboratories have?
Dr. Reddy's Laboratories held ₹86.1 billion in cash and short-term investments at the end of fiscal 2026; with ₹75.8 billion of debt that is net cash of ₹10.3 billion.
What is Dr. Reddy's Laboratories's book value?
Dr. Reddy's Laboratories's shareholders' equity (book value) was ₹369.6 billion at the end of fiscal 2026.
What is Dr. Reddy's Laboratories's current ratio?
Dr. Reddy's Laboratories had current assets of ₹296.0 billion and current liabilities of ₹164.2 billion, a current ratio of 1.80 (it can cover its short-term obligations).
How much goodwill does Dr. Reddy's Laboratories have?
Dr. Reddy's Laboratories carried ₹115.6 billion of goodwill and intangible assets, 20.4% of total assets, at the end of fiscal 2026.